J Hettiarachchi Selected Research

eletriptan (Relpax)

2/2005	Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan.
10/2004	No effect of eletriptan administration during the aura phase of migraine.
7/2004	Effect of high-dose intravenous eletriptan on coronary artery diameter.
11/2003	Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
2/2002	Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Hettiarachchi Research Topics

Disease

4	Headache (Headaches) 02/2005 - 02/2002
4	Migraine Disorders (Migraine) 02/2005 - 02/2002
1	Epilepsy (Aura) 10/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2004
1	Pain (Aches) 02/2002
1	Neurogenic Inflammation 02/2000

Drug/Important Bio-Agent (IBA)

5	eletriptan (Relpax)FDA Link 02/2005 - 02/2002
2	Sumatriptan (Imigran)FDA LinkGeneric 02/2005 - 07/2004
2	Pain-FreeIBA 02/2005 - 11/2003
1	Tryptamines (Triptans)IBA 10/2004
1	naratriptan FDA LinkGeneric 11/2003
1	CP 122288IBA 02/2000

Therapy/Procedure

1	Aftercare (After-Treatment) 02/2002